The opening took place on October 6. We will be posting video highlights of the opening in the near future.


Philipp von Lattorff

”As long as I can remember, we have continuously enlarged our site in Vienna. But the construction of this new biopharmaceutical production facility is unlike anything we’ve done in the past.”

Christian Eckermann

“Biopharmaceuticals are without doubt an important pillar for the future of medicine. Our new high-tech facility sets an example for all of Europe.”

Elisabeth Tomaschko

“For the development of our biopharma operations, we have recruited around 500 new employees, who have found a new professional home with us.”

Courage to Succeed//

We believe in a positive future and have the courage to take the necessary steps to help shape it.

The new production facility is the result of this courage and an investment in human health for the next decades.

This video gives an idea of what we mean by our slogan:


The opening took place on October 6 2021. The evening was being presented by Margit Laufer (ORF). With contributions by:

Philipp von Lattorff

Country Managing Director Boehringer Ingelheim RCV

Hubertus von Baumbach

Chairman of the Board of Managing Directors of Boehringer Ingelheim

Martin Moder

Science Busters

Uwe Bücheler

Head of Corporate Division Biopharmaceuticals Boehringer Ingelheim

Christian Eckermann

Site Head Biopharma Austria

Peter Hanke

Vienna Municipal Councilor

Christian Boehringer

Chairman of the shareholders’ committee at Boehringer Ingelheim


presentation of the site by Parkour Runner

musical entertainment by the Max Steiner Orchestra plus DJ

Production facility//

Flexible, digital, and innovative. The new multi-product biopharmaceutical facility offers progress for the welfare of patients worldwide.

A few impressive facts:


production of pharmaceuticals for heart attacks, strokes, and cancer for the world market


nine 15,000-liter fermenters


apart from the production facility, construction of a new energy center, workshops, works fire department, and logistics and quality building, with a total volume of 390,000 m³


use of AI for process optimization


virtual reality and “smart glasses” for training and inspections

No future without a past

The site enlargement began in April 2017 and was a long and sometimes thorny path. But it was worth it—as this retrospective shows.


Boehringer Ingelheim is a pioneer in Austria in the field of biopharmaceuticals. Already in the 1980s the company produced interferons in cell cultures and continued by specializing in the production of substances with the aid of microorganisms. But what is biopharma exactly and why is it so important for the future of medicine? Watch this video to find out:

Vienna site//

In 1948, Boehringer Ingelheim set up its first foreign subsidiary in Vienna. Over the decades the site has grown and now offers jobs for around 2,400 employees. It is also the hub from which operations in over thirty countries are coordinated.